- Investing Ideas
- /
- Australian Pharmaceuticals & Biotech Large Cap High Growth Potential
Australian Pharmaceuticals & Biotech Large Cap High Growth Potential
Results
1
0 new
Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.
1 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
CSL | AU$283.07 | 1.8% | -1.2% | AU$137.1b | AU$340.56 | PE32.4x | E13.0% | 1.5% |
Page 1 of 1